Drug Shortage Report for LEVOFLOXACIN IN 5% DEXTROSE INJECTION

Last updated on 2024-01-19 History
Report ID 193609
Drug Identification Number 02314932
Brand name LEVOFLOXACIN IN 5% DEXTROSE INJECTION
Common or Proper name LEVOFLOXACIN IN 5% DEXTROSE INJECTION
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) LEVOFLOXACIN
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 24 x 50mL bag
ATC code J01MA
ATC description QUINOLONE ANTIBACTERIALS
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date
Actual start date 2023-09-16
Estimated end date 2024-07-15
Actual end date
Shortage status Actual shortage
Updated date 2024-01-19
Company comments Other presentations remain available
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2024-01-19 French Compare
v9 2024-01-19 English Compare
v8 2023-09-17 English Compare
v7 2023-09-13 French Compare
v6 2023-09-13 English Compare
v5 2023-07-26 French Compare
v4 2023-07-26 English Compare
v3 2023-07-26 English Compare
v2 2023-06-02 French Compare
v1 2023-06-02 English Compare

Showing 1 to 10 of 10